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Abstract 
The physical and immunological properties of the human intestinal epithelial barrier in 
ageing are largely unknown. Ileal biopsies from young (7-12 years), adult (20-40y) and 
ageing (67-77y) individuals not showing symptoms of gastrointestinal pathologies were used 
to assess levels of inflammatory cytokines, barrier integrity, and cytokine production in 
response to microbial challenges. Increased expression of IL-6, but not IFNγ, TNF-α and IL-
1β was observed during ageing; further analysis showed that CD11c+ dendritic cells (DCs) 
are one of the major sources of IL-6 in the ageing gut and expressed higher levels of CD40.  
Up-regulated production of IL-6 was accompanied by increased expression of Claudin-2 
leading to reduced transepithelial electric resistance (TEER); TEER could be restored in in 
vitro and ex-vivo cultures by neutralizing anti-IL-6 antibody. In contrast, expression of 
Zonula occludens-1, Occludin and Junctional-Adhesion Molecule-A1 did not vary with age 
and overall permeability to macromolecules was not affected. Finally, cytokine production to 
different microbial stimuli was assessed in a polarized in vitro organ culture. IL-8 production 
in response to flagellin declined progressively with age although the expression and 
distribution of TLR-5 on intestinal epithelial cells remained unchanged. Also, flagellin-
induced production of IL-6 was less pronounced in ageing. In contrast, TNF-α production in 
response to probiotics (VSL#3) did not decline with age; however, in our experimental model 
probiotics did not down-regulate the production of IL- 6 and expression of Claudin 2. These 
data suggested that ageing affects properties of the intestinal barrier likely to impact on age-
associated disturbances both locally and systemically. 
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Introduction 
A hallmark feature of ageing is immunosenescence and the functional decline of the adaptive 
and innate immune system resulting in compromised immunity to microbial pathogens and 
increased frequency of cancer [1, 2]. These are accompanied by an imbalance between 
inflammatory and anti-inflammatory networks, resulting in low-grade chronic inflammation 
termed inflammaging [3]; converging evidence led to suggest that events in the 
gastrointestinal (GI)-tract that involve interaction between the various components of the 
epithelial barrier and intestinal microbiota might play a central role in this process [4]. 
However, currently our knowledge on the effects of ageing on the physical and 
immunological properties of the intestinal epithelial barrier is very limited. Most importantly 
the lack of knowledge is particularly profound in humans [5]. The gut is the primary and 
largest area of contact with environmental factors and antigens and contains the largest 
number of immune cells in the body and the intestinal barrier is integral to GI-defence in 
preventing or limiting exposure of the host and its immune system to luminal antigens. It is 
made up of several integrated and interactive components that are physical (the epithelium 
and mucus), biochemical (enzymes, anti-microbial proteins), immunological (secretory IgA 
and epithelia-associated immune cells), and microbial (the microbiota) in nature [6]. 
Maintaining barrier integrity is therefore essential for health and defects in intestinal barrier 
function can lead to persistent immune activation and are known to contribute to the 
pathogenesis of intestinal diseases including coeliac disease, colorectal cancer and 
inflammatory bowel disease [6]. However, disturbances of the barrier of the GI-tract might 
have consequences far beyond the gut. This notion is highlighted by the recent observations 
that systemic disorders, ranging from diabetes [7] to major depression [8] and also 
degenerative disorders of the central nervous system (CNS) such as Parkinson’s disease [9] 
and multiple sclerosis (MS) [10] might be linked to events occurring in the intestine. The 
importance of a well-functioning intestinal barrier is further stressed by studies in Drosophila 
demonstrating that impairment of intestinal barrier function predicted age-onset mortality 
[11]. Among the various components of the epithelial barrier the gut epithelium plays a 
pivotal role. Although the primary task of the epithelium is to provide a barrier against 
macromolecules and pathogens it also plays a key role in establishing and maintaining the 
intestinal immune homeostasis and responding rapidly to microbial exposure, thus making it 
a central element of the innate immune system. In a steady-state situation intestinal epithelial 
cells (IECs) secrete cytokines that control the immune intestinal homeostasis by inducing 
anti-inflammatory dendritic cells (DCs) and T regulatory cells [12, 13]. In contrast, the 
presence of pathogenic stimuli causes IECs to release rapidly pro-inflammatory factors, such 
as IL-8 (CXCL-8), MCP-1 (CCL2) and MIP− 3α (CCL20) [14, 15] that provide the first line 
of defence against invading microorganisms. Thus, age-associated changes of epithelial 
innate immunity might have profound effects on both local and systemic immune responses. 
The aim of this study was to investigate age-associated changes of levels of 
inflammatory/regulatory cytokines and their impact on epithelial barrier integrity in the small 
intestine (terminal ileum) and to assess the effect of ageing on intestinal epithelial immunity 
to different types of microbial stimuli. 
.  
 
 
 
4 
 
Material and Methods 
Subjects and biopsies 
Terminal ileum biopsies (up to 8 biopsies/individual) were obtained, with fully informed 
consent and ethical approval during routine endoscopy of patients for preventive screening or 
diagnostic purpose. Donors, 31 adult (20-40 years old); 32 ageing (67-77y) and 19 young (7-
12y) individuals were considered to be healthy when not showing symptoms suggesting 
gastrointestinal inflammatory disease/cancer during endoscopy and histology endoscopic 
inspection and later confirmed by routine histology excluded inflammation and neoplasia. 
Work has been carried out according to the Declaration of Helsinki (2008) and has been 
approved by the appropriate Ethics Committee (Comitato Etico Area Vasta Sud-Est, Italy and  
HRGC, Norwich, UK). All patients provided written informed consent (parental consent for 
children). Subjects had not been under medication for at least three months before the 
endoscopy (including antibiotics, immunosuppressants and steroids). Details of how biopsies 
were processed for the different types of experiment can be found in Supplementary 
Materials Methods. 
Paracellular permeability 
Biopsies were mounted in adapted Ussing chambers exposing a surface of 2.0 mm2. Tissues 
were immersed in Krebs’ solution as described before [16] that was constantly oxygenated by 
a gas flow (95%; O2; 5% CO2) and maintained at 37C. Two pairs of Ag/AgCl electrodes 
were used to monitor the transmucosal potential difference (PD) and short circuit current (Isc) 
that were used to calculate transmucosal resistance according to Ohm’s law. Subsequently the 
solution was replaced with Kreb’s solution containing horseradish peroxidase (HRP type II, 
Sigma Aldrich) and transmucosal transport was carried out as described [16]. Samples were 
collected at 20 minutes intervals for 100 minutes; following incubation with the appropriate 
liquid substrate, 3,3′,5,5′-tetramethylbenzidine (TMB) Liquid Substrate System for ELISA  
(Sigma Aldrich) the reaction was stopped with H2SO4 and samples read at 450nm.  TEER 
was also assessed in Caco-2 cells in the presence or absence of CM from cultures of biopsies 
from the three donor groups. The cells were seeded onto the upper face of Transwell inserts 
(6.5mm diameter, 3.0µm pore size, Corning, Costar) and grown on the filters for 14 days at 
37°C, 5% CO2, until fully differentiated. Transepithelial electric resistance (TEER) was 
monitored at various intervals (Millicell-ERS, Millipore) in the presence or absence of CM 
obtained from biopsy cultures. 
In vitro organ cultures (IVOC) 
Non polarized (np)-IVOC biopsies were mounted on foam support, the foam was saturated 
with a bicarbonate-buffered culture medium consisting of Dulbecco’s minimum essential 
mediumand NCTC-135 medium (1:1) with 10% newborn calf serum plus 0.5% (wt/vol) D-
mannose (all chemicals supplied by Sigma) [17]. Samples were then placed in a 24 well 
culture plate (Costar), covered, placed inside a larger container continuously gassed with 95% 
0-5% C02, at 37C. The polarized (p)-IVOC was a modified version of previously described 
methods [18, 19]. Terminal ileum biopsies of standard size were placed mucosal side up on a 
IVOC-medium soaked nitrocellulose filter (3µm pore) and this was sandwiched between two 
12 mm diameter acrylic  glass (or PVC) disks; with the upper disk provided with a 2mm 
opening prepared in house by workshops at both University of Siena and Norwich Bioscience 
Institute. This was then accommodated into a modified Snapwell chambers (Corning, 
Corning, NY). To avoid antigen and microbial leakage to the basolateral side the upper disc 
was glued to the mucosal side of the biopsy by Histoacryl adhesive.  
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Immunohistochemistry  
Frozen sections were fixed in 10% buffered formalin for 5 minutes and permeabilized with 
0.5% tween-20 for 10 minutes. After rinsing sections were incubated overnight at 4°with 
rabbit anti-TLR5 (Invitrogen) (gift from S. Schueller), quenched with 10% donkey serum, 
and incubated with donkey Cy2-conjugated anti-rabbit IgG (Jackson Immunoresearch) for 60 
minutes. Alternatively, sections were stained with rabbit anti-Claudin 2 antibody (Life 
Techologies) followed by incubation with FITC-labelled anti rabbit IgG antibody (Sigma) 
and counterstained with mouse anti-pan cytokeratin antibody (Sigma) followed by incubation 
with Cy3-conjugated anti-mouse IgG antibody (Jackson Immunoresearch). The primary 
antibody was not added to control sections. Sections were observed with a Zeiss LSM 710 or 
510 confocal microscopes.  
Preparation of conditioned medium (CM) from biopsy culture.  
Immediately after removal biopsies were placed in a plastic tube containing 1 ml IVOC 
medium and kept in 95% O2/5%CO2 atmosphere at 37C for 5-6h ours. Following 
centrifugation (1100rpm x15 min) the conditioned medium (CM) was filtered sterile with 
centrifuge tube filters (0.22µm), aliquoted and stored for no more than 10 days at -80C° until 
used.  
Effects of CM on biopsies and cell culture 
The effects of mucosa-derived soluble mediators present in the CM on tight junction 
expression and intestinal permeability were then assessed in both np-IVOC of biopsies and 
Caco2 cells. Biopsies were cultured in np-IVOC for 10-12 hours in the presence of CM  and 
the medium was replaced with fresh solution every 3-4h. Caco2 cells were cultured in the 
presence of CM for up to 36h and TEER monitored at various intervals. CM was added to 
both compartments of the transwell culture and its volume normalized to the weight of 
biopsies. In some case CM was pre-incubated with varying concentration of either anti-IL-6, 
anti-IL-1β οr anti-TNF-α  antibodies for 3 hours at 4C°. At the end of the culture both tissues 
and Caco2 cells were then used for RNA preparation 
Gene expression  
Total RNA was extracted from human terminal ileum biopsies or Caco2 intestinal epithelial 
cells TRIzol reagent (Invitrogen). Following evaluation of RNA integrity by gel 
electrophoresis RNA reverse transcription was carried out by iScript cDNA synthesis kit 
(Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. The RT-cDNA 
reaction products were subjected to quantitative real-time PCR using the MyiQ single-color 
real-time PCR detection system (Bio-Rad) and iQ SYBR green supermix (Bio-Rad) 
according to the manufacturer's directions. All expression levels were normalized to β-actin 
or GADPH levels of the same sample. Relative quantity of target gene expression to 
housekeeping genes was measured by comparative Ct method. All real-time PCR reactions 
were performed in triplicate. Primers used are described in Supplementary Material Methods. 
Western blot and ELISA 
Western blot analysis and ELISA were carried out according to standard procedures. Details 
of these methods can be found in Supplementary Materials Methods.  
Statistical analysis 
Data were expressed as mean ± SD and analysed using Students’ unpaired T-test or Tukey 
HSD test for multiple samples comparison. A p value < 0.05 was considered significant.  
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Results 
Intestinal levels of IL-6 increased in the ageing human ileum.  
Regulatory cytokines produced by IECs and gut-resident immune cells contribute to establish 
and maintain the intestinal immune homeostasis; however at this time very little is known on 
the effects of age on  levels of regulatory cytokines in the human gut. Initially, two matched 
biopsies from eight individuals from the adult (20-40y) and ageing (67-77y) groups were 
used to monitor the expression of cytokine IL-6, IFN-γ, IL-1β and TNF-α some of which 
have been observed to increase significantly at systemic levels in ageing and are thought to 
underpin the development of frailty and increased mortality in the elderly [2, 3]. No age-
associated changes were observed for TNF-α, IFN-γ and IL-1β among the two age groups. A 
different pattern was observed for IL-6 with the ageing group showing significantly higher 
levels (Figure 1A) (p<0.01). Levels of IL-6 mRNA was then further assessed in additional 5 
individuals/age group that also included individuals between 7-12 years of age (young).  IL-6 
was not detected in two out of five young individuals and in one out of five adults and overall 
it was expressed at lower levels in biopsies from both young and adult individuals compared 
to ageing donors (Figure 1B). Increased tissue levels of IL-6 in the elderly were then 
confirmed at protein level by ELISA (Figure 1C). The amount of IL-6 reached 16.4±4.6 
pg/mg/total protein in the ageing donors compared to both young (5.1±3.0 pg/mg/total 
protein) and adult (5.4.±2.2 pg/mg/total protein) individuals. Furthermore, gene expression 
analysis of cytokeratin (ctk)+ CD45- IECs, CD11c+ DCs and the remaining CD11c- immune 
cell population showed that CD11c+ cell population displayed a significant increase in IL-6 
expression in ageing (p<0.05) (Figure 2A). We observed a trend towards increased 
expression of IL-6 also in IEC although the increase did not reach statistical significance 
(p=0.065). We then focussed on CD11c+ cells. Subsequent analysis of isolated CD11c+ DCs 
showed that similar numbers of CD11c+ cells were recovered from biopsies from donors of 
different ages (Figure 2B). Phenotypic analysis showed that these cells from both groups 
expressed similar levels of CD86 and did not expressed E-Cadherin, a marker for 
inflammation-associated gut-DCs [20]; in contrast, expression of CD40 was higher in 
CD11c+ cells from ageing donors (Figure 2C). Also, isolated CD11c+ DCs from ageing 
donors produced a significant higher levels of IL-6 after 48h in culture (Figure 2D). 
Furthermore the percentage of IL-6-producing CD11c+ cells in the isolated fraction increased 
in ageing individuals (Supplementary Figure S1A-B). It has to be stressed that given the 
difficulties in recruiting patients in the young group (7-12y) we used, for this experiment 
biopsies from adult and ageing individuals only. These data demonstrated an age-associated 
increased production of IL-6; also suggested that, although the role of other cells such as IEC 
cannot be ruled out at this time, CD11c+ cells played an important role in this event.  
Permeability to solutes but not to macromolecules is increased during ageing in the 
small intestine    
The notion that ageing is sometime associated with increased intestinal permeability (leaky 
gut) [21] prompted us to monitor the integrity of the epithelial barrier in biopsies from donors 
of all age groups. Also, given the direct effects of IL-6 on tight junctions, such as Claudin 2  
[22, 23] we investigated the possibility that age-associated overexpression of IL-6 might 
directly affect intestinal permeability. First, we carried post-IVOC structural analysis of the 
terminal ileum by TEM and LM. These did not reveal major age-associated alterations of the 
overall morphology/structure of the TJs and intestinal mucosa and that tissue retained good 
morphology after 10 hour culture in pIVOC (Figure 3A-D). In contrast, subsequent functional 
and molecular analysis of TJs mRNA expression showed the presence of age-associated 
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alterations. First, transepithelial electric resistance (TEER), a measure of the ionic gradient 
across freshly collected ileal biopsies was determined in Ussing chamber. We observed that 
TEER was significantly reduced in biopsies from ageing individuals (p<0.01) while no 
difference was observed between the two younger groups (Figure 3E). Increase of 
permeability in the ageing small intestine appeared to be restricted to solutes, indeed flux of 
HRP (approx. 44kDA) did not vary between the different age groups (Figure 3F) showing 
that permeability to macromolecule was not affected by ageing. Permeability assay was 
paralleled by the analysis of mRNA levels of tight junctions. To this end, mRNA expression 
of Zonula occludens-1 (ZO-1), Occludin, Junctional Adhesion Molecule A 1 (JAMA-1) and 
Claudin-2 was assessed. In contrast to what has been observed previously in colonic biopsies 
of non-human primates [24] we did not observed any significant age-related effect on the 
expression of ZO-1, Occludin and JAMA-1 (Figure 4A-C). On the other hand, in agreement 
with the same report [24] we observed that levels of Claudin-2 were significantly increased 
(p<0.01) in the ageing group compared to adult individuals (Figure 4D) Further 
immunohistochemistry analysis showed absence of age-associated changes in the distribution 
of Claudin 2 in aged tissues (Figure 4F-H)  .  
Age-associated high levels of IL-6 affected intestinal permeability by up-regulating 
Claudin-2 expression. 
To determine whether overexpression of IL-6 in the mucosa of the elderly was in fact 
responsible for the increased intestinal permeability to solutes we tested the effect of 
conditioned medium (CM) from cultures of biopsies of different age on the TEER and 
expression of Claudin-2 in human intestinal epithelial Caco2 cells and biopsies from adult 
donors. Treatment of Caco2 cells with CM from culture of aged biopsies (CMAG) induced a 
significant fall in TEER; instead CM from culture of both young (CMY) and adult biopsies 
(CMAD) did not have any effects on TEER (Figure 5A). Pre-incubation of CMAG with anti-
IL-6 antibody did restore TEER; however, incubation of CM with either anti-TNF-α or IL-1β 
antibody did not have any effect. The result of this functional analysis was confirmed at 
mRNA level. Caco2 cells treated with CMAG showed a significant increase in the expression 
of Claudin-2 compared to untreated Caco2 cells whereas both CMAD and CMY failed to up-
regulate Claudin-2. CMAG-mediated up-regulation of Claudin-2 was suppressed by pre-
incubation with anti-IL-6 but not anti-IL1β or anti-TNF-α antibody (Figure 5B). Culturing 
Caco2 cells in the presence of blocking antibodies alone did not have any effects on both 
TEER and Claudin 2 expression (Supplementary Figure S2). The biological relevance of the 
above results was further confirmed in intestinal biopsies cultured in np-IVOC (Figure 5C). 
Biopsies from young donors showed significantly higher levels of  levels of Claudin-2 when 
cultured in presence of CMAG compared to age-matched untreated biopsies (AD-baseline); 
also in this case pre-incubation with anti-IL-6 but not anti-IL-1β prevented up-regulation of 
Claudin-2. Thus, the collation of in vitro and ex-vivo results showed that increased levels of 
IL-6 appeared to be a feature of the ageing gut that has a direct impact on the expression of 
Claudin-2 with direct bearing on intestinal permeability.  
Production of IL-8 in response to flagellin progressively declined with age. 
The production of cytokine, such as IL-8 in response to flagellin in the gut is an important 
factor in the early stages of the innate immune response to pathogens [25]; we then 
determined whether intestinal response to bacterial components was impaired in ageing.  
Terminal ileum biopsies were then challenged for 10-12 hours with flagellin using a pIVOC 
culture, a model that allows reproducing faithfully real-life host-pathogen interaction by 
restricting the antigenic challenge to the mucosal apical side and that has been already 
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utilized to assess colonic tissue response to soluble flagellin [19]. We observed that a 
significant variation of IL-8 production in response to flagellin occurred across the course of 
life (Figure 6A). Tissue levels of IL-8 reached its highest in the young group (range 35.2-89.8 
pg/mg/total protein), it was significantly reduced (p<0.05) in the adult group (range 24.7-62.6 
pg/mg/total protein) and it declined further in the aged group (p<0.01 and p<0.05 compared 
to young and adult groups respectively) (range 9.2-49.3 pg/mg/total protein). Age-associated 
decline of IL-8 production in response to flagellin was confirmed by western blot analysis 
and subsequent densitometry analysis (Figure 6B, D). Furthermore, although a direct effect of 
IL-6 on the production of IL-8 has not been shown we investigated whether suppression of 
IL-6 could restore IL-8 production in ageing; pre-treatment of biopsies with neutralizing anti-
IL-6  antibody (IgA isotype) did not restore the ability to produce IL-8 in ageing subjects 
(data not shown). Also, expression of flagellin-specific TLR5 was determined at both gene 
and protein level. Quantitative rt-PCR analysis showed that the expression of flagellin-
specific receptor TLR5 did not vary with age (Figure 6C) and immunohistochemistry analysis 
showed absence of age-associated changes in the distribution of mature TLR5 (Figure 6E, F). 
Also, we observed that stimulation with flagellin induced a significant production of IL-6 in 
biopsies from both young and adult individuals but failed to do so in ageing (Supplementary 
Figure S3A) 
Ageing does not affect the ability of probiotics to elicit protective epithelial innate 
immunity. 
It has been shown that probiotics promoted gut health via stimulation of epithelial innate 
immunity, more specifically via the production of TNFα rather than its suppression. Indeed, 
production of TNFα by IEC following challenge with VSL#3 probiotics was found to be a 
critical event in probiotic-mediated prevention/suppression of ileitis [26]. Thus we 
determined as to whether ageing did affect the ability of the gut epithelium to produce TNFα 
in response to VSL#3. The pattern appeared to be different compared to that observed for IL-
8; the production of TNF-α in response to challenge with live VSL#3 probiotics did not vary 
with age (Figure 7A) and challenge with probiotics induced a similar increase in the 
production of TNFα irrespective of the donor’s age. In contrast, it would appear that 
exposure to VSL#3 did not affect the production of IL-6 in biopsies from all age groups 
(Supplementary Figure S3B).  It has also been suggested that probiotics may beneficially 
impact on intestinal permeability. However, we observed there was a trend towards increased 
expression of Claudin 2 possibly as a consequence of increased level of TNFα (Figure 7B); 
this suggested that at least in this experimental setting VSL#3 did not restore the 
compromised intestinal permeability.  
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Discussion 
Compared with immunosenescence of systemic immunity, age-associated changes in the 
mucosal immune system are less well understood. In particular, at intestinal level a major gap 
is represented by the lack of knowledge on events that pertain to the intestinal epithelial 
barrier and early events of the innate immune response. The main aim of the study was to 
investigate the impact of ageing on several aspects of the intestinal barrier including levels of 
inflammatory cytokines, barrier integrity and intestinal innate immunity to different types of 
microbial challenges in humans. Our study showed that ageing affects important physical and 
immunological functions of the intestinal epithelial barrier. Our first objective was to 
determine the levels of inflammatory cytokine in the ageing small intestine (terminal ileum). 
Production of inflammatory cytokine is an important attribute and effector function of IECs 
that influences the activity of various cell types in the intestinal mucosa; also increased levels 
of certain cytokines may have a direct bearing on some of the features of the ageing gut, such 
as increased permeability of the epithelial barrier (“leaky gut”) [21]. Recently it was shown 
that colonic biopsies from aged non-human primates showed increased levels of IL-6, IL-1β 
and IFNγ and reduced expression of TJs such as ZO-1, Occludin and JAMA 1 and increased 
levels of Claudin-2 [24]. Also, alteration of tight junctions led to increased permeability to 
macromolecules (HRP). The pattern appeared to be different in biopsies from the terminal 
ileum of humans. Indeed, we observed that the ageing human small intestine is characterized 
by a significant increase in the level of IL-6 but not of IL-1β, IFNγ or TNF-α as observed in 
primates. Also, we failed to detect major alterations of ZO-1, Occludin and JAMA 1 and no 
changes in permeability to macromolecules (HRP) were observed. It is possible that these 
discordant observations reflected intrinsic differences between humans and non-human 
primates. Alternatively, this might be linked to intrinsic differences between distinct areas of 
the intestine, such as the colon and terminal ileum. The latter hypothesis is supported by the 
recent observation that in humans the regulatory features of DCs varied according to their 
geographical location in the gut (27). Thus, it is possible that while terminal ileum DCs are 
characterized by increased production of IL-6 in ageing, DCs located in the large intestine 
may display a different array of age-related modifications that might lead to a more 
significant alteration of the local inflammatory status and intestinal permeability. One 
consequence of increased intestinal levels of IL-6 is an enhanced permeability to solutes that 
was brought about by up-regulation of the tight junction Claudin-2. In vitro studies have 
shown that IL-6 affects barrier integrity by up-regulating the expression of Claudin 2 [22, 28] 
that in turns promotes the formation of pores that allow paracellular movement of cations and 
small molecules with radii less than 4 Ǻ [23]. It is important to highlight that overexpression 
of Claudin-2 in IECs has been observed in animal model of colitis [29] and patients with 
inflammatory bowel disease [30]. Currently, the contribution of increased expression of 
Claudin-2 to the aetiology or progression of diseases has not yet been determined but it is 
possible that its up-regulation in the elderly could be linked to age-associated disturbances. 
Also, although other cytokines, such as TNF-α can regulate the expression of Claudin-2 [31], 
the observation that the addition of anti-IL-6, but not anti-TNF-α antibody to CM from 
ageing biopsies prevented both Claudin-2 over-expression and decline of TEER strongly 
suggested that IL-6 is the main factor underlying Claudin-2 up-regulation in ageing. Age-
associated increase of IL-6 in the gut raises a series of questions, the most notable being, 
what is the triggering event and what are the potential consequences at systemic level.  
Indeed, although it has been known for some time that ageing in humans is associated with 
increased levels of circulating IL-6 and that this has a strong association with markers of 
physical frailty [32, 33, 34] the cause(s) underlying its increase is still unknown. It has been 
hypothesized that events in the gut might play a critical role in age-associated inflammatory 
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dysregulation [4] and it has been also shown that certain components of the intestinal 
microbiota can induce the production of IL-6 [35]. This together with the notion that 
intestinal microbiota undergoes significant changes in the elderly [36] makes it plausible to 
hypothesize that age-associated alteration of the microbiota that resulted in increased 
presence of IL-6-inducing bacteria species might be one of the triggering events. 
Furthermore, elevated intestinal levels of IL-6 may also directly contribute to establish and 
maintain the age-associated low grade chronic inflammation, or inflammageing [3] at 
systemic level by contributing to promote the differentiation of pro-inflammatory TH17 [37], 
the circulating number of which are significantly higher in the elderly [38]. Although at this 
time we cannot rule out the possibility that other cell types, such as IECs may contribute to 
increased levels of IL-6 in ageing we observed that CD11c+ DCs played a role in this event. 
Also, these cells are characterized by increased expression of CD40 that together with IL-6 
secretion is highly relevant to the generation of TH17 in vivo [39].  Furthermore, by 
extending our study to the immunological features of the intestinal barrier in response to 
microbial antigen of different nature we observed that the production of cytokines in the gut 
in response to different microbial challenges in ageing may or may not decline, possibly 
depending on the nature of the antigenic stimulus. Indeed, while epithelial production of IL-8 
in response to flagellin progressively declined across life and it is significantly compromised 
in ageing the production of TNFα in response to exposure to probiotics did not decline in the 
elderly. Interestingly, in contrast to a previous report [40] elevated levels of IL-6 did not 
affect the expression of flagellin-specific TLR5 on IECs that remained unchanged in ageing. 
Thus, it would seem that increased levels of IL-6 alone did not suffice to inducing major 
changes of the expression of TLR5 and dysregulation of the major tight junctions. This would 
suggest that a simultaneous up-regulation of several pro-inflammatory cytokines is required 
to induce significant detrimental effects on the intestinal epithelial barrier. Also, the notion 
that levels of TLR5 did not change with age also strongly suggested that the progressive age-
dependent decline in production of IL-8 is due to alteration of intracellular signalling 
pathways following the engagement of flagellin with TLR5. Ultimately it is likely that 
reduced levels of IL-8 may play an important role in the increased susceptibility of the 
elderly to infections.  In contrast, TNF-α production in response to a more complex microbial 
challenge, such as live VSL#3 probiotic mixture did not show significant variation between 
the age groups. The latter finding is of potential interest. First, although studies conducted in 
mice and cell lines have shown that probiotics promoted gut health by inducing the 
production of the pro-inflammatory cytokine TNFα, rather than its suppression [26], their 
effect on the human gut was still unknown. Second, very little attention has been given so far 
to how the intestinal response to probiotics varies between individuals of different age. Our 
results demonstrated that VSL#3 induced the production in the human gut of TNFα, which 
plays an important role in preventing/ameliorating ileitis in mice [26] and that age does not 
influence the production of a cytokine required for the beneficial effects of probiotics. On the 
other hand, we have shown that in vitro challenge with VSL#3 probiotic mixture did not 
down-regulate the expression of Claudin 2 thus suggesting that a short term exposure to 
VSL#3 as carried out in our ex-vivo experimental model was not enough to beneficially affect 
the partially compromised intestinal permeability. We believe that the identification of the 
triggering events affecting aspects of the epithelial barrier integrity and intestinal epithelial 
innate immune response to certain antigenic stimuli, such as flagellin is a goal of certain 
medical relevance, and may provide us with the tool to impact on local and possibly systemic 
age-associated disorders. 
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Clinical Perspectives 
The effects of ageing on physical and immunological properties of the intestinal epithelial 
barrier in humans are largely unknown. We report that the ageing gut is characterized by 
higher levels of the cytokine IL-6 that in part affects intestinal permeability. Furthermore, 
ageing is associated with an impaired intestinal innate immunity to microbial challenge in the 
small intestine that might lead to the increased susceptibility to infections typical of the aged 
organisms. This study suggests a pivotal role of the gut in the generation of the chronic low-
grade inflammatory status (termed ‘inflammaging’) typical of the aged organism; it also 
provides the basis to hypothesize that manipulating the composition of the intestinal 
microbiota in the elderly may represent an important strategy to intervene on age-associated 
disorders both locally and systemically.   
Author contribution 
Claudio Nicoletti, Eugenio Bertelli and Alastair Watson designed the study; Mario Marini 
and Graham Briars designed the study from a clinical point of view, produced ethical 
approval and provided human samples; Angela Man, Eugenio Bertelli, Mari Regoli and 
Silvia Rentini conducted the research and analysed data; Claudio Nicoletti, Eugenio Bertelli 
and Alastair Watson wrote the paper. 
Acknowledgements 
The authors wish to thank S. Schueller and S.R. Carding for helpful comments and discussion 
and P. Pople for computer artwork.  
Funding. This work was supported by the Biotechnology and Biological Sciences Research 
Council (BBSRC), UK, Institute Strategic Programme Grant [BB/J004529/1: The Gut Health 
and Food Safety-ISP] (to CN) and intramural funds from University of Siena, Italy (to EB).  
 
 
 
 
 
 
 
 
 
 
 
 
 
12 
 
References 
1- Ershler W.B. (2003) Biological interactions of aging and anemia: a focus on cytokines, 
J. Am. Geriatr. Soc. 51, S18-21. 
2- Gardner I.D. (1980) The effect of aging on susceptibility to infection, Rev. Infect. Dis. 
2, 801-810. 
3- Franceschi C., Campisi J. (2014) Chronic inflammation (inflammageing) and its 
potential contribution to age-associated diseases. J Gerontol. 69, Suppl1:S4-9 doi: 
10.1093/gerona/glu057 . 
4- Guigoz Y., Dore J.  Schiffrin E.J. (2008) The inflammatory status of old age can be 
nurtured from the intestinal environment, Curr. Opin. Clin. Nutr. Metab. Care. 11, 13-
20 
5- Man AL, Gicheva N, Nicoletti C. (2014) The impact of ageing on the intestinal 
epithelial barrier and immune system. Cell Immunol. 289, 112-118 
6- Turner JR. (2009) Intestinal mucosal barrier function inhealth and disease. Nature Rev 
Immunol. 9, 799-809 
7- Bleau C, Karelis AD, St-Pierre DH, Lamontagne L. (2014). Crosstalk between 
intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic 
low-grade inflammation and the development of obesity and diabetes. Diabetes Metab 
Res Rev. 2, doi: 10.1002/dmrr.2617 
8- Maes M, Kubera M, Leunis JC (2008) The gut-brain barrier in major depression: 
intestinal mucosal dysfunction with an increased translocation of LPS from gram 
negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology 
of depression. Neuro Endocrinol Lett. 9, 117-24. 
9- C.B. Forsyth C.B., K.M. Shannon K.M., J.H. Kordower J.H., Voigt RM, Shaikh M, 
Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A.(2011) Increased intestinal 
permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin 
exposure markers in early Parkinson's disease, PLoS One 6, e28032. 
10-  A. Vrieze A., P.F. de Groot P.F., R.S. Kootte R.S., Knaapen M, van Nood E, 
Nieuwdorp M (2013) Fecal transplant: a safe and sustainable clinical therapy for 
restoring intestinal microbial balance in human disease? Best Pract. Res. Clin. 
Gastroenterol. 27, 127-137. 
11- Rera M., Clark R.I., Walker D.W. (2012) Intestinal barrier dysfunction links metabolic 
and inflammatory markers of aging to death in Drosophila, Proc. Natl. Acad. Sci. U. S. 
109, 21528-21533. 
12-  Rimoldi M, Chieppa M, Salucci V., Avogadri F, Sonzogni A, Sampietro GM, Nespoli 
A, Viale G, Allavena P, Rescigno M. (2005) Intestinal immune homeostasis is 
regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol. 6, 
507-514 
13-  Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M (2009) Intestinal epithelial 
cells promote colitis-protective regulatory T-cell differentiation through dendritic cell 
conditioning Mucosal Immunol. 2, 340-50 
14-  Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. (2003) 
Nat Rev Immunol. 4, 331-341 
15- Sansonetti P.J. War and peace at mucosal surfaces. (2004) Nat Rev Immunol. 4, 953-
964 
16- Greenwood-Van Meerveld B, Tyler K, Keith JC Jr. (2000) Recombinant human 
interleukin-1 modulates ion transport and mucosal inflammation in the small intestine 
and colon.Lab Invest. 80:1269-1280. 
13 
 
17- Hicks S., Candy DC, Phillips AD (1996) Adhesion of enteroaggregative Escherichia 
coli to pediatric intestinal mucosa in vitro. Infect Immun. 64:4751-60 
18- El Asmar R, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, Catassi C, Fasano A 
(2002) A. Host-dependent zonulin secretion causes the impairment of the small 
intestine barrier function after bacterial exposure. Gastroenterology. 123,1607-15 
19- Schuller S., Lucas M. Kaper J.B., Girón JA, Phillips AD (2009) The ex-vivo response 
of human intestinal mucosa to enteropathogenic E. coli infection. 11:1607-1615 
20- Siddiqui K R., Laffon S, Powrie F. (2010) E-Cadherin Marks a Subset of Inflammatory 
Dendritic Cells that Promote T Cell-Mediated Colitis Immunity. 23, 32: 557–567 
21- Hollander D., Tarnawski H. (1985) Aging-associated increase in intestinal absorption 
of macromolecules Gerontology. 31, 133-137 
22- Suzuki T, Yoshinaga N, Tanabe S. (2011) Interleukin-6 (IL-6) regulates Claudin-2 
expression          and tight junction permeability in intestinal epithelium. J Biol Chem. 
286:31263-31271 
23- Van Itallie C.M., Holmes J., Bridges A, Gookin JL, Coccaro MR, Proctor W, 
ColegioOR, Anderson JM (2008) The density of small tight junction pores varies 
among cell types and is increased by expression of claudin-2. J Cell Sci. 121, 298-305 
24- Tran L., Greenwood-Van Meerveld B. (2013) Age-associated remodeling of the 
intestinal epithelial barrier. J. Gerontol. A Biol. Sci. Med. Sci. 68, 1045-1056. 
25- Eckmann L, Kagnoff MF, Fierer J (1993) Epithelial cells secrete the chemokine 
interleukin-8 in response to bacterial entry. Infect Immun. 61:4569-74 
26- Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F  (2010) 
Probiotics  promote gut health through stimulation of epithelial innate immunity. Proc 
Natl Acad Sci U S A. 107:454-459 
27- Mann ER, Bernardo D, English NR, Landy J, Al-Hassi HO, Peake ST, Man R, 
Elliott TR, Spranger H, Lee GH, Parian A, Brant SR, Lazarev M, Hart AL, Li X, 
Knight SC (2015). Compartment-specific immunity in the human gut: properties and 
functions of dendritic cells in the colon versus the ileum. Gut. pii: gutjnl-2014-307916. 
doi: 10.1136/gutjnl-2014-307916 
28- Al-Sadi R, Ye D, Boivin M, Guo S, Hashimi M, Ereifej L, Ma TY. (2014) Interleukin-
6 modulation of intestinal epithelial tight junction permeability is mediated by JNK 
pathway activation of claudin-2 gene. PLoS One. 9, e85345. doi: 
10.1371/journal.pone.0085345.  
29- Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz  J, Gitter 
AH, Bürgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. (2015) 
Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects 
epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 129, 550–
564 
30- Fujino S., Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y 
(2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut  52, 
65–70 
31- Mankertz J., Amasheh M., Krug S.M, Fromm A, Amasheh S, Hillenbrand B, Tavalali 
S, Fromm M, Schulzke JD (2009) TNF-α up-regulates claudin-2 expression in 
epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling Cell Tissue Res. 
336, 67-77 
32- Ershler W.B., Keller ET..(2000) Age-associated increased interleukin-6 gene 
expression, late-life diseases, and frailty. Annu Rev Med. 51, 245-70 
33- Roubenoff R. (2014) The cytokine for gerontologist has some company. J. Gerontol. A 
Biol. Sci. Med. Sci. 69:163-64 
14 
 
34- Sanders J.L., Ding V., Arnold A.M, Kaplan RC, Cappola AR, Kizer JR, Boudreau RM, 
Cushman M, Newman AB  (2014) Do changes in circulating biomarkers track with 
each other and with functional changes in older adults?. J. Gerontol. A Biol. Sci. Med. 
Sci. 68:174-81 
35- Ivanov I.I., Atarashi K., Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb 
KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda 
K, Littman DR (2009) Induction of intestinal Th17 cells by segmented filamentous 
bacteria. Cell. 139:485-498 
36- Claesson .J., Jeffery .IB., Conde S, Power SE, O'Connor EM, Cusack S, Harris HM,  
Coakley M, Lakshminarayanan B, O'Sullivan O, Fitzgerald GF, Deane J, O'Connor M,  
Harnedy N, O'Connor K, O'Mahony D, van Sinderen D, Wallace M, Brennan L, 
Stanton  C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O'Toole 
PW(2012) Gut microbiota composition correlates with diet and health in the elderly 
Nature. 488:178-84 
37- Kimura A., Kishimoto T. IL-6: regulator of Treg/Th17 balance (2010) Eur J Immunol. 
40, 830-835 
38- Schmitt V., Rink L., Uciechowski P. (2013) The Th17/Treg balance is disturbed during 
aging. Exp Gerontol. 48:1379-1386 
39- Perona-Wright, Jenkins SJ, O’Connor RA, Zienkiewicz D, McSorley HJ, Maizels RM, 
Anderton SM, MacDonald AS. (2009). A pivotal role for CD40-mediated IL-6 
production by dendritic cells during IL-17 induction in vivo. J Immunol. 182:2808-15 
40- Sánchez-Muñoz F., Fonseca-Camarillo G., Villeda-Ramírez M.A., Miranda-Pérez E, 
Mendivil EJ, Barreto-Zúñiga R, Uribe M, Bojalil R, Domínguez-López A, Yamamoto-
Furusho JK . (2011) Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with 
inflammatory activity in Ulcerative Colitis. BMC Gastroenterol. 11:138-142 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
Legends 
Figure 1- Levels of regulatory cytokines in the small intestine of individuals of different age. 
A pair of terminal ileum biopsies/subject collected from adults (n=10; 20-40y; grey bars) and 
ageing (n=10; 67-77y; black bars) individuals were used to assess expression of cytokine 
genes (A). IL-6 showed a significant increase in the ageing group (p<0.01), no changes were 
seen for TNFα, IL-1β or IFNγ. Statistical analysis was carried using Student’s unpaired t-test. 
Age-associated increase of IL-6 was subsequently confirmed in additional 5/individual 
groups that included also young (7-12y) subjects (B). Finally, increased tissue levels of IL-6 
were confirmed at protein levels by ELISA in a pair of terminal ileum biopsies/subject 
(n=10/group) in all age group (C); IL-6 tissue levels are expressed relative to amounts of total 
protein. ND= not detected.  
Figure 2- Expression of IL-6 in isolated intestinal cell populations. Three cell populations, 
IEC (Ctk+CD45-), CD11c-CD45+ and CD11c+CD45+ were isolated from biopsies (6-8 
biopsies/individual) of donors (5 individuals/group) of different age and assessed for IL-6 
expression (A). A trend towards increase of IL-6 expression was observed in IEC although 
the difference did not reach statistical significance (*, p=0.06); whereas IL-6 production was 
significantly increased in CD11c+ DCs (**). The purified CD11c+ cells (B) were then 
assessed for the expression of co-stimulatory molecules (C); DCs from both age groups 
displayed similar expression of CD40, lack of expression of E-Cadherin while higher 
expression of CD40 was observed in the ageing group. Increased production of IL-6 by 
CD11c+ cells from ageing donors was further confirmed by ELISA using culture (48h) 
supernatants. This set of experiments was performed using only biopsies from adult 
(n=5/group; 20-40y) and ageing (67-77y) individuals for difficulties to recruit donors in the 
young group. Statistical analysis was carried out using Student’s unpaired t-test. 
Figure 3- Intestinal permeability to solutes and macromolecules in ageing. Post-IVOC (10 
hours) TEM micrographs of the structure of tight junctions in freshly isolated biopsies from 
young (A), adult (B) and ageing (C) individuals did not show any visible age-associated 
morphological alteration; also, intestinal tissues retained good morphology after pIVOC. (D). 
The overall integrity of the structure of the ageing gut also appeared to be intact at lower 
magnification (D) where a series of adjoining TJs are illustrated (boxes). TEER declined in 
ageing as established in Ussing chambers (E); however, permeability to macromolecules 
(HRP, approx. 44kDA) remained unchanged (F). Statistical analysis was carried using Tukey 
HSD test for multiple samples comparison 
Figure 4- Expression of tight junctions in the ageing gut. Level of expression of ZO-1, 
Occludin and JAMA-1 (A-C) were similar in biopsies from all age groups. In contrast, 
Claudin 2 was significantly up-regulated in ageing individuals (D) (p<0.01) compared to 
younger individuals. Each symbol represents the average from two biopsies/individual (6-8 
individuals/group). Statistical analysis was carried using Tukey HSD test for multiple 
samples comparison; asterisk (*) indicates significance difference.  Also, expression of 
Claudin 2 did not change with age (E-H). Cross section of biopsies (apical area) from adult 
(E) and ageing (F) individuals showed that Claudin-2 (green) is restricted to the tight junction 
complex between adjacent epithelial cells (IEC). Similar distribution was seen in longitudinal 
section of biopsies from adult (G) and ageing (H) individuals; also in this case Claudin 2 
(green), arrow heads) was restricted at the apical domain (L=lumen) as part of the tight 
junction complex. Sections were counterstained with anti-pan cytokeratin antibody (red). As 
average, 3-5 sections from 3 biopsies/donor (3 donors/group) were examined. 
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Figure 5- Conditioned medium from cultures of ageing biopsies affected intestinal 
permeability and expression of Claudin 2. Caco2 cells (A) were cultured in the presence of 
conditioned medium (CM) from young (CMY), adult (CMAD) and ageing (CMAG) individuals 
and TEER monitored for at least 36h.  Both CMAD and CMAG did not have a significant effect 
on intestinal permeability, in contrst, addition of CMAG to the culture had a significant impact 
on permeability that became evident after 18h. Pre-incubation of CMAG with anti-IL-6 
antibody but not anti-IL1β or anti-TNF-α prevented CMAG-mediated increased permeability. 
rt-PCR analysis carried out after 24h culture in the presence of CMAG showed that IL-6 
underpins the up-regulation of Claudin-2 expression (B). In (C) biopsies from adult donors 
cultured in the presence of CMAG (AD-CMAG) showed higher expression levels of Claudin-2 
compared to untreated biopsies from adults (AD-baseline) and comparable to what observed 
in biopsies from ageing donors (AD). Addition of anti-IL6 antibody (AD-CMAG-αIL6) but 
not anti-IL1β (AD-CMAG-αIL1β) prevented upregulation of Claudin-2. Statistical analysis 
was carried using Tukey HSD test for multiple samples comparison; different letters indicate 
statistical difference; equal letters indicate lack of statistical difference.  Asterisk (*) indicates 
significance difference. 
Figure 6- Intestinal response to flagellin. Tissue levels of IL-8 in response to flagellin were 
assessed after 10 hours p-IVOC. Levels of IL-8 progressively declined from young 
individuals to adult and continued to do further so in ageing subjects (A) as seen by ELISA. 
IL-8 tissue levels are expressed relative to amounts of total protein. Age-dependent variation 
of tissue levels IL-8 following challenge with flagellin is shown also by western blot analysis 
(B) and associated densitometric analysis (D); data are representative of three independent 
experiments with similar results. mRNA levels of TLR5 remained unchanged throughout life 
(C) and expression of TLR5 did not increase after stimulation compared to unchallenged 
tissue, irrespective of the age of the donor. Finally, immunohistochemistry analysis showed 
absence of age-associated changes in the distribution of mature TLR5 (E, F).  Statistical 
analysis was done using Tukey HSD test for multiple samples comparison (A) and Student’s 
unpaired t-test was used in (C). 
Figure 7- VSL#3 probiotics induced normal production of TNFα in ageing but did not down-
regulated expression of Claudin 2. Challenge of biopsies with live probiotics for 10 hours in 
p-IVOC induced the production of similar levels of TNF-α irresepctive of the donor's age. 
Levels of TNF-α are expressed relative to amounts of total protein. Furthermore, we 
observed a trend (not statistically significant) towards increased expression of Claudin 2 in 
ageing tissue  following challenge with VSL#3 probiotic mixture (B), thus suggesting that 
age-associated Claudin 2-mediated up-regulation of intestinal permeability was not reduced 
by probiotics challenge, at least under these experimental conditions. Statistical analysis was 
done using Tukey HSD test for multiple samples comparison (A) and Student’s unpaired t-
test was used in (B). 
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